Gefiwel Gefitinib Tablets 250 Mg

Name: Gefiwel Gefitinib Tablets 250 Mg
Brand: welox pharma

Introduction to Gefiwel

Gefiwel (Gefitinib Tablets 250 mg) is an oral targeted therapy used for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations.

Uses of Gefiwel

Treatment of advanced or metastatic non-small cell lung cancer (NSCLC)

First-line therapy for patients with EGFR-positive lung cancer

Benefits of Gefiwel

Specifically targets and inhibits EGFR-mutant cancer cells

Offers an effective alternative to traditional chemotherapy

Well-tolerated with a favorable safety profile

Convenient once-daily oral dosage

Mechanism of Action of Gefiwel

Gefitinib inhibits EGFR tyrosine kinase, blocking the signaling pathways that promote cancer cell growth and survival.